Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,230
Closed -$1.01M 158
2021
Q4
$1.01M Buy
9,230
+2,970
+47% +$299K 0.2% 65
2021
Q3
$573K Buy
+6,260
New +$618K 0.12% 71
2020
Q1
Sell
-2,174
Closed -$217K 109
2019
Q4
$217K Buy
+2,174
New +$202K 0.05% 111
2019
Q3
Sell
-7,100
Closed -$589K 97
2019
Q2
$589K Buy
7,100
+100
+1% +$7.85K 0.15% 87
2019
Q1
$537K Sell
7,000
-1,071
-13% -$78.6K 0.15% 90
2018
Q4
$517K Hold
8,071
0.22% 84
2018
Q3
$610K Sell
8,071
-1,153
-13% -$86.8K 0.29% 62
2018
Q2
$714K Buy
9,224
+3,459
+60% +$257K 0.35% 63
2018
Q1
$383K Buy
5,765
+1,729
+43% +$129K 0.2% 82
2017
Q4
$331K Buy
4,036
+1,269
+46% +$102K 0.16% 85
2017
Q3
$214K Buy
+2,767
New +$199K 0.12% 85
2017
Q2
Sell
-38,971
Closed -$2.35M 60
2017
Q1
$2.35M Buy
+38,971
New +$2.02M 1.66% 31

Other funds holding FMC

Parkside Investments's FMC Position: Q1 2022 in Review

Parkside Investments sold out of FMC (FMC) in Q1 2022, closing a stake of 9,230 shares — an estimated $1.01M sold.

Parkside Investments first reported a position in FMC in Q1 2017 and held it in 12 quarters. The position peaked at $2.35M in Q1 2017. 639 funds tracked by Wall St. Rank hold FMC as of Q1 2022.

  • Parkside Investments reported no remaining FMC position as of Q1 2022 after selling out during the quarter.
  • Parkside Investments sold 9,230 FMC shares in Q1 2022, an estimated $1.01M.
  • Parkside Investments first reported a position in FMC in Q1 2017 and held it in 12 quarters.
  • Parkside Investments's FMC position peaked at $2.35M in Q1 2017.
  • 639 funds tracked by Wall St. Rank held FMC as of Q1 2022.

Based on Parkside Investments's 13F filing for Q1 2022, filed 2 May 2022.